Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The use of post-marketing studies for diabetes is being used to sell more medicines rather than for science, according to a new investigation by the BMJ.
Post-marketing studies are primarily used to show that a new drug is safe and effective in the real world.
But there are concerns that many of these studies are predominantly serving a marketing purpose ? to promote new, more expensive treatments and influence the prescribing habits of physicians.
Experts warn that these studies are fuelling a ?catastrophic health expenditure? in low income countries, and a former drug industry employee told the BMJ that many of these studies ?had more marketing than science behind them?.
http://www.inpharm.com/news/173018/bmj-diabetes-post-marketing-studies-used-boost-sales
Post-marketing studies are primarily used to show that a new drug is safe and effective in the real world.
But there are concerns that many of these studies are predominantly serving a marketing purpose ? to promote new, more expensive treatments and influence the prescribing habits of physicians.
Experts warn that these studies are fuelling a ?catastrophic health expenditure? in low income countries, and a former drug industry employee told the BMJ that many of these studies ?had more marketing than science behind them?.
http://www.inpharm.com/news/173018/bmj-diabetes-post-marketing-studies-used-boost-sales